Xp11.2 translocation renal cell carcinomas have a poorer prognosis than non-xp11.2 translocation carcinomas in children and young adults: A meta-analysis

International Journal of Surgical Pathology

Volumn 18, Issue 6, 2010, Pages 458-464

  Qiu Rao, ^a   Bing Guan, ^a   Zhou, Xiao Jun ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

pediatric renal cell carcinoma; prognosis; TFE3; Xp11.2 translocation carcinomas

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER STAGING; CHROMOSOME TRANSLOCATION; CHROMOSOME XP; DISEASE FREE SURVIVAL; HUMAN; INCIDENCE; KIDNEY CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS;

ADULT; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARCINOMA, RENAL CELL; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, X; DISEASE-FREE SURVIVAL; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; PROGNOSIS; TRANSLOCATION, GENETIC; YOUNG ADULT;

EID: 78649292895     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896910375565     Document Type: Article

References (23)

1. Cook A., Lorenzo AJ, Salle JL, et al. Pediatric renal cell carcinoma: single institution 25-year case series and initial experience with partial nephrectomy. J Urol. 2006 ; 175: 1456-1460 ; discussion 1460.
2. Argani P. The evolving story of renal translocation carcinomas. Am J Clin Pathol. 2006 ; 126: 332-334.
3. Winarti NW, Argani P., De Marzo AM, et al. Pediatric renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion. Int J Surg Pathol. 2008 ; 16: 66-72.
4. Jing H., Tai Y., Xu D., et al. Renal cell carcinoma associated with Xp11.2 translocations, report of a case [published online ahead of print October 23, 2009]. Urology. doi:10.1016/ j.urology.2009.07.1276.
5. Lopez-Beltran A., Scarpelli M., Montironi R., et al. 2004 WHO classification of the renal tumors of the adults. Eur Urol. 2006 ; 49: 798-805.
6. Martignoni G., Pea M., Gobbo S., et al. Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas. Mod Pathol. 2009 ; 22: 1016-1022.
7. Argani P., Ladanyi M. Recent advances in pediatric renal neoplasia. Adv Anat Pathol. 2003 ; 10: 243-260.
8. Argani P., Lal P., Hutchinson B., et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol. 2003 ; 27: 750-761.
9. Dickson BC, Brooks JS, Pasha TL, et al. TFE3 expression in tumors of the microphthalmia-associated transcription factor (MiTF) family [published online ahead of print February 16, 2010]. Int J Surg Pathol. doi:1066896909352861v1.
10. Geller JI, Dome JS Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma. Cancer. 2004 ; 101: 1575-1583.
11. Geller JI, Argani P., Adeniran A., et al. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread. Cancer. 2008 ; 112: 1607-1616.
12. Bovio IM, Allan R., Oliai B., et al. Xp11.2 translocation renal carcinoma with placental metastasis: a case report [published online ahead of print January 22, 2009]. Int J Surg Pathol. doi:1066896908331231v1.
13. Koie T., Yoneyama T., Hashimoto Y., et al. An aggressive course of Xp11 translocation renal cell carcinoma in a 28-year-old man. Int J Urol. 2009 ; 16: 333-335.
14. Jadad AR, Moore RA, Carroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary ? Control Clin Trials. 1996 ; 17: 1-12.
15. Kjaergard LL, Villumsen J., Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med. 2001 ; 135: 982-989.
16. Higgins JP, Thompson SG Quantifying heterogeneity in a meta-analysis. Stat Med. 2002 ; 21: 1539-1558.
17. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003 ; 327: 557-560.
18. Ramphal R., Pappo A., Zielenska M., et al. Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family. Am J Clin Pathol. 2006 ; 126: 349-364.
19. Wu A., Kunju LP, Cheng L., et al. Renal cell carcinoma in children and young adults: analysis of clinicopathological, immunohistochemical and molecular characteristics with an emphasis on the spectrum of Xp11.2 translocation- associated and unusual clear cell subtypes. Histopathology. 2008 ; 53: 533-544.
20. Rao Q., Chen YJ, Wang DJ, et al. Renal cell carcinoma in children and young adults: clinicopathological, immunohistochemical, and VHL gene analysis of 46 cases with follow-up [published online ahead of print December 24, 2009]. Int J Surg Pathol. doi:1066896909354337v1.
21. Moher D., Pham B., Jones A., et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses ? Lancet. 1998 ; 352: 609-613. (Pubitemid 28380142)
22. Srigley JR, Delahunt B. Uncommon and recently described renal carcinomas. Mod Pathol. 2009 ; 22 (suppl 2). S2 - S23.
23. Rais-Bahrami S., Drabick JJ, De Marzo AM, et al. Xp11 translocation renal cell carcinoma: delayed but massive and lethal metastases of a chemotherapy-associated secondary malignancy. Urology. 2007 ; 70: 178. e3 - e6.